ARCHIVES

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 18 No. 46 | November 27, 1992

Download PDF Visit The Full Archive

Related Articles

CMS Proposes To End Automatic Coverage Of Clinical Trials For Medicare Patients.

October 12, 2007

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

ICCCR to Focus Its Efforts on Prevention Research

February 22, 1991

Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter

October 15, 1976

DCPC board Oks New Grant Program For Investigators

March 4, 1994

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013